tiprankstipranks
Trending News
More News >
Extendicare (TSE:EXE)
TSX:EXE
Canadian Market
Advertisement

Extendicare (EXE) Technical Analysis

Compare
210 Followers

Summary of all the Indicators

Overall Consensus
Sell
7Bullish
5Neutral
10Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Extendicare’s (EXE) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Extendicare is a Buy.
Extendicare’s (EXE) 20-Day exponential moving average is 13.03, while Extendicare’s (EXE) share price is C$12.99, making it a Sell.
Extendicare’s (EXE) 50-Day exponential moving average is 13.13, while Extendicare’s (EXE) share price is C$12.99, making it a Sell.

Extendicare (EXE) Pivot Points

Sep 06, 2025, 09:52 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.67
12.75
12.85
12.93
13.03
13.11
13.21
Fibonacci
12.75
12.82
12.86
12.93
13.00
13.04
13.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Extendicare (EXE) Moving Averages

Sep 06, 2025, 09:52 AM
Period
Simple
Exponential
MA5
12.97Buy
12.99Buy
MA10
13.02Sell
13.02Sell
MA20
13.14Sell
13.03Sell
MA50
13.08Sell
13.13Sell
MA100
13.47Sell
13.01Sell
MA200
12.25Buy
11.94Buy
Extendicare’s (EXE) 10-Day exponential moving average is 13.02, while Extendicare’s (EXE) share price is C$12.99, making it a Sell.
Extendicare’s (EXE) 100-Day exponential moving average is 13.01, while Extendicare’s (EXE) share price is C$12.99, making it a Sell.
Extendicare’s (EXE) stock price is C$12.99 and Extendicare’s (EXE) 50-day simple moving average is 13.08, creating a Sell signal.
Extendicare’s (EXE) stock price is C$12.99 and Extendicare’s (EXE) 100-day simple moving average is 13.47, creating a Sell signal.
Extendicare’s (EXE) stock price is C$12.99 and Extendicare’s (EXE) 200-day simple moving average is 12.25, creating a Buy signal.

Extendicare (EXE) Technical Indicators

Sep 06, 2025, 09:52 AM
Name
Value
Implied Action
RSI (14)
48.24
Neutral
STOCH (9,6)
44.44
Neutral
STOCHRSI (14)
33.13
Neutral
MACD (12,26)
-0.02
Buy
ADX (14)
18.17
Buy
Williams %R
-63.54
Buy
CCI (14)
-66.62
Neutral
ATR (14)
0.27
-
Ultimate Oscillator
44.57
Neutral
ROC
-3.35
Sell
Extendicare’s (EXE) Relative Strength Index (RSI) is 48.24, creating a Neutral signal.
Extendicare’s (EXE) Trend Strength Indicator (ADX) is 18.17, creating a Buy signal.
Extendicare’s (EXE) Commodity Channel Index (CCI) is -66.62, creating a Neutral signal.
Extendicare’s (EXE) Price Rate of Change (ROC) is -3.35, creating a Sell signal.

FAQ

Is EXE a Buy, Hold, or Sell?
Based on EXE’s technical indicators, EXE is a Sell.
    What is EXE’s RSI (14)?
    EXE’s RSI (14) is 48.24, which suggests EXE is a Neutral.
      What is EXE’s MACD?
      EXE’s MACD is -0.02, which suggests EXE is a Buy.
        What is EXE’s 5-day moving average?
        EXE’s 5-day moving average is 12.97, which suggests EXE is a Buy.
          What is EXE’s 20-day moving average?
          EXE 20-day moving average is 13.14, which suggests EXE is a Sell.
            What is EXE’s 50-day moving average?
            EXE’s 50-day moving average is 13.08, which suggests EXE is a Sell.
              What is EXE’s 200-day moving average?
              EXE’s 200-day moving average is 12.25, which suggests EXE is a Buy.
                What is EXE’s Williams % R (14)?
                EXE’s Williams % R (14) is -63.54, which suggests EXE is a Buy.
                  What is EXE’s CCI (14)?
                  EXE’s CCI (14) is -66.62, which suggests EXE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis